Resultados de la búsqueda

de Frutos F, Gonzalez-Lopez E. New challenges in the management of patients with transthyretin cardiac amyloidosis: beyond oral anticoagulation. Rev Esp Cardiol (2023) S1885-5857:00031-2

Barreiro-Pérez M, Pueyo PP, Roubin SR, Corominas DM, Uribarri A, Bachiller RE, Rozado Castaño J, Álvarez LG, Fernández LS, Domínguez F, Figal DP. Consenso de expertos sobre el diagnóstico y el tratamiento de la miocarditis asociada con infección o vacunación contra el SARS-CoV-2 [Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management]. Rev Esp Cardiol (2023) 76:555-563
Link to the full text in Repisalud

Porres-López E, de Frutos F, Silva-Hernández L, Galán L, González-López E, García-Pavía P. Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador. Rev Esp Cardiol (2023) S1885-5857(23)00045-2

González-Gómez A, Fernández-Golfín C, Hinojar R, Monteagudo JM, García A, García-Sebastián C, García-Lunar I, Sánchez-Recalde Á, Salido L, Pardo A, Zamorano JL. The 4A classification for patients with tricuspid regurgitation. Rev Esp Cardiol (2023) 76:845-851

Pascual-Figal D, Lax A, Asensio López MC. Circulating ST2, from biomarker to pathogenic mediator. Rev Esp Cardiol (2023) S1885-5857(23)00102-0
Link to the full text in Repisalud

Rodríguez-Leor O, Rosselló X, Cid-Álvarez AB, Pérez de Prado A. Results from the ACI-SEC Infarction Code Registry. The ECG also exists. Response. Rev Esp Cardiol (2023) S1885-5857(23)00109-3.

Vela Martín P, Matutano Muñoz A, Sánchez Ortiz D, Domínguez F, Royuela A, Cobo Marcos M. CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure. Rev Esp Cardiol (2023) 76:477-480

Barreiro-Pérez M, Pastor Pueyo P, Raposeiras-Roubín S, Montero Corominas D, Uribarri A, Eiros Bachiller R, Rozado Castaño J, García-Cuenllas Álvarez L, Serratosa Fernández L, Domínguez F, Pascual Figal D. Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. Rev Esp Cardiol (2023) 76:555-563
Link to the full text in Repisalud

Castellano JM, Fuster V. Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy Rev Esp Cardiol (2023) 76:1055-1060

López-Azor JC, Delgado JF, Vélez J, Rodríguez R, Solís J, Del Oro M, Ortega C, Salguero-Bodes R, Palacios B, Vicent L, Moreno G, Rosillo N, Varela L, Capel M, Arribas F, Bernal JL, Bueno H. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction. Rev Esp Cardiol (2023) 76:862-871.